Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10789
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Azad, Arun A | en |
dc.contributor.author | Chong, Geoffrey | en |
dc.contributor.author | Tauro, A | en |
dc.contributor.author | Aly, Ahmad | en |
dc.contributor.author | Tebbutt, Niall C | en |
dc.date.accessioned | 2015-05-16T00:21:18Z | - |
dc.date.available | 2015-05-16T00:21:18Z | - |
dc.date.issued | 2009-03-19 | en |
dc.identifier.citation | Medical Oncology (northwood, London, England) 2009; 27(2): 230-2 | en |
dc.identifier.govdoc | 19296240 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/10789 | en |
dc.description.abstract | We present the case of a 65-year-old male with squamous cell carcinoma of the thoracic oesophagus on a background of neurofibromatosis type 1. On computed tomography, he was noted to have a large left-sided superior mediastinal mass. Initially, this mass was thought to be metastatic lymphadenopathy; however, it did not display fluorodeoxyglucose uptake on positron emission tomography. Subsequent biopsy confirmed the mass to be a neurofibroma and the patient commenced definitive chemo-radiation. Positron emission tomography had a major impact on management since the presumed lymph node disease was not included in the radiation field. In addition, positron emission tomography altered prognostic stratification since lymph node involvement is a poor prognostic factor in oesophageal cancer. We could only identify one other case in the English literature in which positron emission tomography was used to distinguish metastatic carcinoma from a neurofibroma, although there are a number of reports that describe the utility of positron emission tomography in differentiating benign neurofibromas from malignant connective tissue tumours. | en |
dc.language.iso | en | en |
dc.subject.other | Aged | en |
dc.subject.other | Diagnosis, Differential | en |
dc.subject.other | Esophageal Neoplasms.diagnosis.radionuclide imaging.secondary | en |
dc.subject.other | Fluorodeoxyglucose F18.diagnostic use | en |
dc.subject.other | Humans | en |
dc.subject.other | Male | en |
dc.subject.other | Neurofibroma.diagnosis.radionuclide imaging | en |
dc.subject.other | Positron-Emission Tomography | en |
dc.title | 18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Medical oncology (Northwood, London, England) | en |
dc.identifier.affiliation | Ludwig Institute Oncology Unit, University of Melbourne, Austin Hospital, Austin Health, Heidelberg, Victoria, Australia, Australia | en |
dc.identifier.doi | 10.1007/s12032-009-9196-x | en |
dc.description.pages | 230-2 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/19296240 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Aly, Ahmad | |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.openairetype | Journal Article | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
19296240.pdf | 44.46 kB | Adobe PDF | View/Open |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.